Clinical Trials Directory

Trials / Unknown

UnknownNCT05541237

Type 2 Diabetes Intervention by Gut Microbiota-directed Diet -a Open Labelled RCT

Type 2 Diabetes Intervention by Gut Microbiota-directed Diet -a Open Labelled Randomized Controlled Trials

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Qilu Hospital of Shandong University · Academic / Other
Sex
All
Age
30 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study is a randomized, open labelled, placebo-controlled clinical trial. The main purpose is to verify the superior effect of gut microbiota directed diet intervention over standard diet intervention by evaluating the changes of HbA1c relative to baseline at 16 weeks and 28 weeks of follow-up.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTFoodFood

Timeline

Start date
2022-08-17
Primary completion
2023-09-05
Completion
2024-09-08
First posted
2022-09-15
Last updated
2023-03-24

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05541237. Inclusion in this directory is not an endorsement.

Type 2 Diabetes Intervention by Gut Microbiota-directed Diet -a Open Labelled RCT (NCT05541237) · Clinical Trials Directory